Previously Unreported Chromosomal Aberrations of t(3;3)(q29;q23), t(4;11)(q21;q23), and t(11;18)(q10;q10) in a Patient with Accelerated Phase Ph+ CML
Author(s) -
Çiğdem Aydın,
Zafer Çetin,
Ozan Salim,
Orhan Kemal Yücel,
Levent Ündar,
Sibel Berker Karaüzüm
Publication year - 2014
Publication title -
case reports in genetics
Language(s) - English
Resource type - Journals
eISSN - 2090-6544
pISSN - 2090-6552
DOI - 10.1155/2014/582016
Subject(s) - chromosomal translocation , trisomy , trisomy 8 , medicine , chronic myelogenous leukemia , supernumerary , leukemia , karyotype , biology , microbiology and biotechnology , chromosome , genetics , immunology , gene , dentistry
Chronic myelogenous leukemia (CML) is a clonal hematological disorder, which is characterized by the presence of the classical or variant Philadelphia translocations. During the progression to blastic phase of the disease secondary chromosomal abnormalities may emerge. Such secondary chromosomal abnormalities are nonrandom, the more frequent ones being trisomy 8 and 19, supernumerary i(17q), and extra Philadelphia chromosomes. Furthermore, a minor percentage of the patients may acquire different secondary chromosomal abnormalities including translocations between other chromosomes. We report here a patient with Ph+ CML presenting secondary chromosomal abnormalities including t(4;11)(q21;q23), t(3;3)(q29;q23) and t(11;18)(q10;q10) during the course of CML progression.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom